Morningstar® Stock Report™

Medtronic PLC MDT

Último Precio
79.74
Cambio del día
0.49|0.62%

a 26/04/2024
17:56:30 EDT | USD  Retraso mínimo: 15 minutos

Bid/OffersRango del DíaVolumen90d Ave VolCapitalización
79.00 - 80.0078.95 - 79.855,024,5976,339,976105.90Bil
Último Cierre52 Week RangeP/UDividendo %ISIN
79.2568.84 - 92.0225.163.48IE00BTN1Y115

Cotización Medtronic

Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
Cuentas Financieras
202120222023
Más...
Cuenta de Resultados
Ingresos30,117.0031,686.0031,227.00
Resultado Operativo4,895.005,908.005,830.00
Resultado Neto3,606.005,039.003,758.00
Beneficio Básico por Acción2.683.752.83
Num Medio Acciones diluidas en circulación1,3541,3511,333
Balance
Activo Corriente22,548.0023,059.0021,675.00
Activos no corrientes70,534.0067,920.0069,274.00
Total Activo 93,083.0090,981.0090,948.00
Pasivo corriente8,509.0012,394.009,051.00
Total Pasivo---
Capital Total51,428.0052,551.0051,483.00
Flujo de Caja
Flujo de caja operativo6,240.007,346.006,039.00
Inversiones de Capital-1,355.00-1,368.00-1,459.00
Flujo de Caja Libre4,885.005,978.004,580.00

En millones, excepto "EPS básico". La moneda es USD.

Perfil de la compañía

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Sector

Atención sanitaria

Industria

Dispositivos Médicos

Estilo de acciones

Grande-Valor

Fin Ejercicio Fiscal

abril

Empleados

95,000
Principales Características
Más...
Precio/Beneficio 12 m25.08
Precio/Valor contable2.03
Precio/Ventas TTM3.27
Crec Ingresos (media 3 a)2.60
Crec BPA (media 3 a)-
Margen operativo18.67
Margen neto12.03
ROE 12 m7.22
Deuda/Fondos propios0.47
Dividendos
AntÚltimo
Fecha declarada07/12/2307/03/24
Ex-Div19/12/2321/03/24
Pagado12/01/2412/04/24
Cantidad0.690.69
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures